Page last updated: 2024-11-02

oxidopamine and Advanced Sleep Phase Syndrome

oxidopamine has been researched along with Advanced Sleep Phase Syndrome in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ben, V1
Bruguerolle, B1

Other Studies

1 other study available for oxidopamine and Advanced Sleep Phase Syndrome

ArticleYear
Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study.
    Life sciences, 2000, Aug-18, Volume: 67, Issue:13

    Topics: Animals; Body Temperature; Corpus Striatum; Disease Models, Animal; Heart Rate; Locomotion; Male; Ox

2000